Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Lewy body dementia (LBD), including dementia with Lewy bodies and Parkinson’s disease dementia, affects over a million people in the USA and has a substantial impact on patients, caregivers, and society. Symptomatic treatments for LBD, which can include cognitive, neuropsychiatric, autonomic, sleep,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alzheimers Res Ther
Главные авторы: Goldman, Jennifer G., Forsberg, Leah K., Boeve, Bradley F., Armstrong, Melissa J., Irwin, David J., Ferman, Tanis J., Galasko, Doug, Galvin, James E., Kaufer, Daniel, Leverenz, James, Lippa, Carol F., Marder, Karen, Abler, Victor, Biglan, Kevin, Irizarry, Michael, Keller, Bill, Munsie, Leanne, Nakagawa, Masaki, Taylor, Angela, Graham, Todd
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7597002/
https://ncbi.nlm.nih.gov/pubmed/33121510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00703-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы